Cargando…

Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice

There is increasing clinical evidence to suggest a suppressive effect on hematopoiesis in myelodysplastic syndrome patients with iron overload. However, how iron overload influences hematopoiesis in myelodysplastic syndrome (MDS) remains unknown. Here, the RUNX1S291fs-transduced bone marrow mononucl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Xin, He, Xiaoyuan, Cao, Xiaoli, Xu, Ping, Xing, Yi, Sui, Songnan, Wang, Luqiao, Meng, Juanxia, Lu, Wenyi, Cui, Rui, Ni, Hongyan, Zhao, Mingfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165791/ https://www.ncbi.nlm.nih.gov/pubmed/29903757 http://dx.doi.org/10.3324/haematol.2018.193128

Ejemplares similares

ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice
por: Chai, Xiao, et al.
Publicado: (2015)

Corrigendum: ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice
por: Chai, Xiao, et al.
Publicado: (2017)

Effects of Iron Overload on the Bone Marrow Microenvironment in Mice
por: Zhang, Yuchen, et al.
Publicado: (2015)

HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation
por: Jin, Xin, et al.
Publicado: (2019)

Iron Overload in Myelodysplastic Syndromes: Pathophysiology, Consequences, Diagnosis, and Treatment
por: Lyle, Lindsey, et al.
Publicado: (2018)

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
por: Gattermann, Norbert
Publicado: (2008)

The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia
por: Weber, Sarah, et al.
Publicado: (2021)

Iron Overload in Hematopoietic Stem Cell Transplantation
por: Yasri, Sora, et al.
Publicado: (2017)

The role of magnetic resonance imaging in the evaluation of transfusional iron overload in myelodysplastic syndromes
por: Petrou, Emmanouil, et al.
Publicado: (2015)

High expression of APAF-1 elevates erythroid apoptosis in iron overload myelodysplastic syndrome
por: Gu, Shucheng, et al.
Publicado: (2013)

The impact of iron overload in patients with acute leukemia and myelodysplastic syndrome on hepatic and endocrine functions
por: Yassin, Mohamed A, et al.
Publicado: (2018)

Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children
por: Lee, J W, et al.
Publicado: (2009)

Iron Overload in Patients Undergoing Hematopoietic Stem Cell Transplantation
por: Pullarkat, Vinod
Publicado: (2010)

Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells
por: Luo, Bingqing, et al.
Publicado: (2022)

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
por: Dussiau, Charles, et al.
Publicado: (2023)

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome
por: de Montalembert, Mariane, et al.
Publicado: (2017)

Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation
por: Atilla, Erden, et al.
Publicado: (2017)

Iron overload in myelodysplastic syndromes (MDS) – diagnosis, management, and response criteria: a proposal of the Austrian MDS platform
por: Valent, P, et al.
Publicado: (2008)

Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study
por: Cilloni, Daniela, et al.
Publicado: (2020)

Plasma Levels of Aminothiols, Nitrite, Nitrate, and Malondialdehyde in Myelodysplastic Syndromes in the Context of Clinical Outcomes and as a Consequence of Iron Overload
por: Pimková, Kristýna, et al.
Publicado: (2014)

A Case Report of Hepatocellular Carcinoma in a Non-cirrhotic Patient With Liver Iron Overload Associated With Myelodysplastic Syndrome
por: Ikoma, Naruhiko, et al.
Publicado: (2013)

Iron overload disorders
por: Hsu, Christine C., et al.
Publicado: (2022)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality
por: Dimitriou, Marios, et al.
Publicado: (2016)

Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy
por: Pinto, Valeria, et al.
Publicado: (2015)

Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma
por: Cao, Yaqing, et al.
Publicado: (2019)

Body iron metabolism and pathophysiology of iron overload
por: Kohgo, Yutaka, et al.
Publicado: (2008)

Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo
por: Knorr, Katherine L.B., et al.
Publicado: (2016)

Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome
por: Wei, Yunxiong, et al.
Publicado: (2021)

What is new in iron overload?
por: Vermylen, Christiane
Publicado: (2007)

Inherited Disorders of Iron Overload
por: Pantopoulos, Kostas
Publicado: (2018)

Iron overload and liver cancer
por: Molina-Sánchez, Pedro, et al.
Publicado: (2019)

Differential Reponses of Hematopoietic Stem and Progenitor Cells to mTOR Inhibition
por: Yang, Aimin, et al.
Publicado: (2015)

DETERMINATION OF FERRITIN AND HEMOSIDERIN IRON IN PATIENTS WITH NORMAL IRON STORES AND IRON OVERLOAD BY SERUM FERRITIN KINETICS
por: SAITO, HIROSHI, et al.
Publicado: (2012)

HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study
por: De Souza, Geane Felix, et al.
Publicado: (2015)

Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures
por: Masala, Erico, et al.
Publicado: (2018)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

The Role of Iron and Iron Overload in Chronic Liver Disease
por: Milic, Sandra, et al.
Publicado: (2016)

Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei
por: He, Xiaoyuan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_39u699343kao71hefks6d63kue